Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Gross Profit Growth (3y) (2012 - 2026)

Bio-Rad Laboratories (BIO) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 9.77%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 12.24%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 4.81%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 14.82%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 9.36%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 14.95%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 3.96%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 3.99%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 8.95%
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -1.56%

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.56%
Mar 31, 2026 -5.13%
Dec 31, 2025 -4.56%
Sep 30, 2025 -2.68%
Jun 30, 2025 -4.38%
Mar 31, 2025 -8.74%
Dec 31, 2024 -5.08%
Sep 30, 2024 -6.58%
Jun 30, 2024 -3.98%
Mar 31, 2024 -6.64%
Dec 31, 2023 -7.32%
Sep 30, 2023 -2.95%
Jun 30, 2023 7.35%
Mar 31, 2023 4.52%
Dec 31, 2022 6.32%
Sep 30, 2022 6.67%
Jun 30, 2022 8.67%
Mar 31, 2022 8.89%
Dec 31, 2021 6.34%
Sep 30, 2021 15.04%